Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 21, 1430-1435, November 1, 1961]
© 1961 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Origenes, M. L.
Right arrow Articles by Labbe, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Origenes, M. L., Jr.
Right arrow Articles by Labbe, R. F.

Effects of Ehrlich Ascites Tumor on Iron Incorporation into Heme*

Mauricio L. Origenes, Jr., Edward L. Lester and Robert F. Labbe

( Department of Pediatrics, University of Washington, Seattle, Washington)

The Ehrlich ascites tumor takes up intravenous Fe59 and utilizes much of this for cellular heme formation. In vivo experiments showed that the amount of iron utilized by liver and marrow for heme synthesis was directly related to the amount of iron taken up by these tissues. In vitro experiments revealed no difference in iron-protoporphyrin chelation by liver mitochondria from control and tumor-bearing mice. There was likewise no evidence of insufficient iron for heme synthesis in these mitochondria. Large injections of iron had no effect on liver catalase activity in control or tumor-bearing mice. It was concluded that any decrease in liver heme synthesis due to a tumor could possibly be related to a decreased {delta}-aminolevulinic acid dehydrase activity but not to any effect at the site of iron-protoporphyrin chelation.

* Aided by research grants from the American Cancer Society (P-184A) and the National Institute for Arthritis and Metabolic Diseases, U.S. Public Health Service (A-2164).

Received 6/ 1/61.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1961 by the American Association for Cancer Research.